Rosen, national trial counsel, encourages the chemours company investors to inquire about securities class action investigation - cc

New york , feb. 25, 2024 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of the chemours company (nyse: cc) resulting from allegations that chemours may have issued materially misleading business information to the investing public. so what: if you purchased chemours securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
CC Ratings Summary
CC Quant Ranking